Early Hemoperfusion with Polymyxin B Improves Lung Function in Sepsis
Author Information
Author(s): Kushi Hidehiko, Miki Takahiro, Okamoto Kazuhiko, Nakahara Jun, Saito Takeshi, Tanjoh Katsuhisa
Primary Institution: Nihon University School of Medicine
Hypothesis
The inhibitory effect of PMX on activation of chemokines, neutrophils, and vascular endothelial cells is associated with improvement in the PaO2/FiO2 ratio.
Conclusion
DHP-PMX significantly decreased blood levels of PAI-1, NE, and IL-8, and significantly improved the PaO2/FiO2 ratio.
Supporting Evidence
- All patients remained alive after 1 month.
- The mean blood levels of PAI-1, NE, and IL-8 were significantly decreased from 48 hours after the start of DHP-PMX treatment.
- The mean PaO2/FiO2 ratio was significantly improved from 96 hours after the start of DHP-PMX treatment.
- There were significant negative correlations between the PaO2/FiO2 ratio and blood levels of NE and IL-8.
Takeaway
This study found that a treatment called DHP-PMX helps sick patients breathe better by cleaning harmful substances from their blood.
Methodology
Thirty-six patients with sepsis underwent DHP-PMX treatment, and levels of various mediators and the PaO2/FiO2 ratio were measured before and after treatment.
Potential Biases
The study design does not allow for definitive conclusions about causality due to lack of control group.
Limitations
This was a prospective uncontrolled observational study with a limited number of patients.
Participant Demographics
Patients were aged 28-85 years, with 21 men and 15 women.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website